Artificial Cells, Nanomedicine, and Biotechnology

Taylor & Francis Group

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Artificial Cells, Nanomedicine, and Biotechnology is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,875 EUR. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Taylor & Francis Group
ISSN
2169-1401 · 2169-141X
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,875 EUR
Articles in DOAJ
1057
Declared review time
20 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2019-11-07
  • MEDLINE · 2013-01-01
Indexing
DOAJ · MEDLINE
APC
2,875 EUR
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1057

Most recent article

last month

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

2303

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

112

i10-index

1646

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2023-07-18
Added to DOAJ
2019-11-07
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
81%
ORCID iDs in current deposits
82%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Artif Cells Nanomed Biotechnol
Source type
journal
NLM unique ID (PubMed)
101594777
Classification4

Subjects (DOAJ)

Technology: Chemical technology: BiotechnologyMedicine: Medicine (General): Medical technology

LCC codes

TP248.13-248.65R855-855.5

Subject areas

  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Nanoparticles: synthesis and applications
  • Nanoparticles: synthesis and applications
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
Show all subjects (50)
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Graphene and Nanomaterials Applications
  • Graphene and Nanomaterials Applications
  • Circular RNAs in diseases
  • Circular RNAs in diseases
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Electrospun Nanofibers in Biomedical Applications
  • Electrospun Nanofibers in Biomedical Applications
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Bone Tissue Engineering Materials
  • Bone Tissue Engineering Materials
  • Hemoglobin structure and function
  • Hemoglobin structure and function
  • Mesenchymal stem cell research
  • Mesenchymal stem cell research
  • Tissue Engineering and Regenerative Medicine
  • Tissue Engineering and Regenerative Medicine
  • Electrochemical sensors and biosensors
  • Electrochemical sensors and biosensors
  • Curcumin's Biomedical Applications
  • Drug Solubulity and Delivery Systems
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Curcumin's Biomedical Applications
  • Drug Solubulity and Delivery Systems
  • Heme Oxygenase-1 and Carbon Monoxide
  • Heme Oxygenase-1 and Carbon Monoxide
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Wound Healing and Treatments
  • Wound Healing and Treatments
  • Essential Oils and Antimicrobial Activity
  • Essential Oils and Antimicrobial Activity
  • Advanced Nanomaterials in Catalysis
  • Advanced Nanomaterials in Catalysis

Keywords (DOAJ)

  • artificial cells
  • nanotechnology
  • nanobiotechnology
  • biotechnology
  • molecular biology
  • bioencapsulation

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: